2. Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) (A151216)

    Submitted by centretek on Sat, 10/15/2022 - 10:30
    Summary
    This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

  6. A Clinical Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) in Subjects At Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) (REBUILD)

    Submitted by centretek on Sat, 10/15/2022 - 10:30

  7. A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with Pelacarsen (TQJ230) on major cardiovascular events in patients with established cardiovascular disease (Horizon)

    Submitted by centretek on Sat, 10/15/2022 - 10:30
Subscribe to